Trump’s 200% Generic Drug Tariff Plan Puts India’s Pharma Exports in Focus
US President Donald Trump has announced a phased tariff policy on imported generic medicines, proposing duties of up to 200%…
Tariff
Read More
Trump Threatens Pharma Firms with 5-8% Tariffs Ahead of October Drug Price Deadline
The Trump administration has held back for now on imposing steep new tariffs on imported pharmaceuticals, even as Donald Trump…
US Seeks Tariff Cuts; India Demands Full Exemption
The United States is currently negotiating a limited trade agreement with India during a 90-day pause on recently imposed tariffs,…